Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-05-29
2007-05-29
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S336000
Reexamination Certificate
active
11107447
ABSTRACT:
Disclosed are compounds which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such compounds are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The compounds can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.
REFERENCES:
patent: 5510332 (1996-04-01), Kogan et al.
patent: 330 506 (1989-08-01), None
patent: WO 96/01644 (1996-01-01), None
Melik-Ogandzhanian, R. “Synthesis and antitumor activity of some N-2,5-dimethyloxazolo [5,4-d]pyrimidinyl-7-amino acids.”Chemical Abstracts104(34):795, col. 1 (1986).
Abraham et al.J. Clin. Invest. 93:776 (1994).
Bao et al.Diff. 52:239 (1993).
Baron et al.J. Clin. Invest. 93:1700 (1994).
Baron et al.J. Exp.Med. 177:57 (1993).
Burkly et al.Diabetes43:529 (1994).
Cybulsky et al.Science251:788 (1991).
Elices et al.Cell60:577-584 (1990).
Elices et al.J. Clin. Invet. 93:405 (1994).
Hamann et al.J. Immunology152:3238 (1994).
Kawaguchi et al.Japanese J. Cancer Res. 83:1304 (1992).
Lauri et al.British J. Cancer68:862 (1993).
Li et al.Arterioscler. Thromb. 13:197 (1993).
Mulligan et al.J. Immunology150:2407 (1993).
Okarhara et al.Cancer Res. 54:3233 (1994).
Osborn et al.Cell6(2):3-6 (1990).
Paavonen et al.Int. J. Can. 58:298 (1994).
Paul et al.Transpl. Proceed. 25:813 (1993).
Postigo et al.J. Clin. Invest. 89:1445 (1991).
Pretolani et al.J. Exp. Med. 180:795 (1994).
Sasseville, et al.Am. J. Path. 144:27 (1994).
Schadendorf et al.J. Path. 170:429 (1993).
Springer, et al.Nature346:425-434 (1990).
vanDinther-Janssen et al.J. Immunology147:4207 (1991).
vanDinther-Janssen et al.Annals. Rheumatic Dis. 52:672 (1993).
Vedder et al.Surgery106:509 (1989).
Yang et al.Proc. Nat. Acad. Science(USA) 90:10494 (1993).
Yednock et al.Nature356:63 (1992).
Ashwell Susan
Dressen Darren B.
Grant Francine S.
Konradi Andrei W.
Kreft Anthony
Elan Pharmaceuticals Inc.
Kifle Bruck
Wyeth
LandOfFree
Beta-amino acid derivatives-inhibitors of leukocyte adhesion... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Beta-amino acid derivatives-inhibitors of leukocyte adhesion..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Beta-amino acid derivatives-inhibitors of leukocyte adhesion... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3755607